Keyphrases
RNA Splicing
100%
SLCO1B3
100%
Skin Cancer Therapy
100%
Trans-splicing
42%
Cell Death
28%
Apoptosis
28%
Pre-mRNA
28%
Marker Genes
28%
Epidermolysis Bullosa
28%
Minigene
28%
Suicide Gene
28%
Tumor Cells
14%
Coding Sequence
14%
Western Blot Analysis
14%
Quantitative RT-PCR
14%
Squamous Cell Carcinoma (SqCC)
14%
Cell Apoptosis
14%
Tumor-specific
14%
Screening System
14%
Squamous Carcinoma Cells
14%
Skin Cancer Cells
14%
Apoptosis Assay
14%
Cell Viability Assay
14%
Tumor Marker
14%
Targeted Tumor
14%
Death Systems
14%
HSV-TK
14%
Target mRNA
14%
Biochemistry, Genetics and Molecular Biology
Trans Splicing
100%
SLCO1B3
87%
Cell Death
25%
Precursor mRNA
25%
Marker Gene
25%
Epidermolysis bullosa
25%
Minigene
25%
Programmed Cell Death
25%
Cancer Cell
12%
Cell Viability
12%
Western Blot
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Tumor Marker
12%
Apoptosis Assay
12%
Messenger RNA
12%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Cancer
100%
SLCO1B3
100%
Neoplasm
28%
Squamous Cell Carcinoma
28%
Epidermolysis bullosa
28%
Messenger RNA Precursor
28%
Western Blot
14%
Cell Viability
14%
Apoptosis Assay
14%
Tumor Marker
14%
Messenger RNA
14%
Immunology and Microbiology
Trans-Splicing
100%
Programmed Cell Death
37%
Cell Death
25%
Marker Gene
25%
Cancer Cell
12%
Tumor Cell
12%
Cell Viability
12%
Western Blot
12%
Squamous Cell
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Squamous Cell Carcinoma Cell
12%